Brain scans track Alzheimer's protein in At-Risk group
NCT ID NCT03089827
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 23 times
Summary
This study looks at 800 people already enrolled in an Alzheimer's research center. Researchers use a special brain scan to measure amyloid, a protein linked to Alzheimer's. The goal is to see how amyloid builds up over time, which may help find the best time to start treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.